Theravance Biopharma Receives FDA Fast Track Designation for TD-8954 for Use With Enteral Feeding in Critically Ill Patients

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/7/2026

1. MU
2. SPCX
3. APTX:CN
4. SPY
5. IQMX
6. EROC
7. MSTR
8. MSFT
9. SEER
10. NVDA

Go back to Theravance Biopharma Receives FDA Fast Track Designation for TD-8954 for Use With Enteral Feeding in Critically Ill Patients
(NASDAQ: TBPH) Delayed: 17.00 +0.07 (0.41%)
Previous Close $16.93    52 Week High $38.92 
Open $17.00    52 Week Low $12.87 
Day High $17.05    P/E N/A 
Day Low $16.94    EPS $0.00 
Volume 596,963